FDA Inspection
RedPharm DrugFDA Inspection 1277212 - RedPharm Drug - August 01, 2025
Record Details
This FDA Inspection record concerns RedPharm Drug, with an inspection on August 1, 2025, issued by the Minneapolis District Office, covering human drugs.
View Company Profile
ID · e00d068f-93e8-4290-9b3b-d7e6a5f46c3c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1277212
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.25(a)GMP Training Frequency
- 21 CFR 211.22(a)Contract drug products--lack of responsibility
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of RedPharm Drug
3| Date | Classification | Office | Project area |
|---|---|---|---|
| November 3, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 11, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 29, 2009 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for RedPharm Drug
- FDA Inspection 1030658 - 2017-11-03
- FDA Inspection 848068 - 2013-09-11
- FDA Inspection 636090 - 2009-12-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.